CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.260

-3.8%

Nov 11 3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Norton who started this subject	9/26/2000 12:13:30 PM
From: tom r. phillips	Read Replies (1) of 668

Jim McCamant (Medical Tech Stock Letter) on CNBC in last hour called CRIS a biotech stock everybody should own. CRIS was one of four he mentioned in that "must have" category. stock got an immediate pop (beginning ~11:50am EDT). maybe his plug will part of the critical mass of interest-generating news and PR to launch CRIS post-merger. many expect approval of OP-1 bone morphogenic protein device this fall or early winter in at least one of Europe, Australia, or USA. Europe may be most likely -- CRIS CEO Doros Platika reported last week that European inspectors have visited Stryker's OP-1 manufacturing facility. also, check out the hiring notices re. OP-1: op-1.com looks like another brick in the wall re. signs of imminent approval of OP-1 somewhere. tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next